Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery

Nanotechnology

Volumn 20, Issue 35, 2009, Pages

  Mandal, Biman B ^a   Kundu, S C ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXINS; ANTI-APOPTOTIC PROTEIN; ANTICANCER DRUG; APOPTOTIC PROTEINS; BREAST CANCER; BREAST CANCER CELLS; CELLULAR UPTAKE; CYTOTOXICITY ASSAYS; DOWN-REGULATION; DRUG LOADING; ENCAPSULATED NANOPARTICLES; HYDROPHOBIC AND HYDROPHILIC; IN-CELL; IN-VITRO; INDUCED APOPTOSIS; MCF-7 CELLS; MICELLAR NANOPARTICLES; MICROSCOPIC STUDY; NANOCARRIERS; NANOPARTICLE SIZES; NATURAL BIOMATERIALS; PACLITAXEL; PLURONIC F-127; POLOXAMER; REGULATORY PROTEIN; SELF ASSEMBLED NANOPARTICLES; SELF-ASSEMBLED; SILK SERICIN; TARGET SITES; TARGETED DELIVERY; TARGETED DRUG DELIVERY; UP-REGULATION; WESTERN-BLOT ANALYSIS;

BIOLOGICAL MATERIALS; CELL DEATH; CELL MEMBRANES; CYTOTOXICITY; DRUG DELIVERY; HYDROGELS; HYDROPHILICITY; HYDROPHOBICITY; LAWS AND LEGISLATION; NANOPARTICLES; SILK; TISSUE ENGINEERING;

VANADIUM;

BIOMATERIAL; FLUORESCEIN ISOTHIOCYANATE; INULIN; LIPOCORTIN 5; NANOCARRIER; NANOPARTICLE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; POLOXAMER; PROTEIN BAX; PROTEIN BCL 2; SERICIN; SOLVENT; ANTINEOPLASTIC AGENT; DRUG CARRIER;

APOPTOSIS; ARTICLE; ASSAY; CANCER CELL; CELL STRAIN MCF 7; COCONUT; CONFOCAL MICROSCOPY; CYTOTOXICITY; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENCAPSULATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; LIGHT SCATTERING; PARTICLE SIZE; PRIORITY JOURNAL; SILK; STAINING; UPREGULATION; WESTERN BLOTTING; WORM; ANIMAL; CELL DEATH; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECT; FLOW CYTOMETRY; METABOLISM; SURFACE PROPERTY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANNEXIN A5; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROSCOPY, CONFOCAL; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; POLOXAMER; SERICINS; SILK; SURFACE PROPERTIES;

EID: 70249094971     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/20/35/355101     Document Type: Article

References (63)

1. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M and Kataoka K 2005 Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy Bioconjug. Chem. 16 122
2. Alonso M J 2004 Nanomedicines for overcoming biological barriers Biomed. Pharmacother. 58 168
3. Duncan R 2003 The dawning era of polymer therapeutics Nat. Rev. Drug. Discov. 2 347
4. Moghimi S M and Hunter A C 2000 Poloxamers and poloxamines in nanoparticle engineering and experimental medicine Trends Biotechnol. 18 412
5. Kabanov A V, Batrakova E V and Alakhov V Y 2002 Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery J. Control. Release 82 189
6. Hosseinkhani H and Hosseinkhani M 2009 Biodegradable polymer-metal complexes for gene and drug delivery Curr. Drug Safety 4 79
7. Hosseinkhani H, Hosseinkhani M, Khademhosseini A and Kobayashi H 2007 Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold J. Control. Release 117 380
8. Hosseinkhani H and Yasuhiko T 2006 Self assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells J. Nanosci. Nanotechnol. 6 2320
9. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H and Tabata Y 2006 Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile nanofibers Biomaterials 27 4079
10. Hosseinkhani H 2006 DNA nanoparticles for gene delivery to cells and tissue Int. J. Nanotechnol. 3 416
11. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H and Tabata Y 2006 Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration Biomaterials 27 5836
12. Hosseinkhani H, Hosseinkhani M and Kobayashi H 2006 Proliferation and differentiation of mesenchymal stem cells using self-assembled peptide amphiphile nanofibers Biomed. Mater. 1 8
13. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H and Tabata Y 2006 Ectopic bone formation in collagen sponge self-assembled peptide-amphiphile nanofibers hybrid scaffold in a perfusion culture bioreactor Biomaterials 27 5089
14. Hosseinkhani H, Hosseinkhani M, Gabrielson N P, Pack D W, Khademhosseini A and Kobayashi H 2008 DNA nanoparticles encapsulated in 3D tissue-engineered scaffolds enhance osteogenic differentiation of mesenchymal stem cells J. Biomed. Mater. Res. A 85 47
15. Hosseinkhani H and Hosseinkhani M 2008 Suppression effect of basic fibroblast growth factor on mesenchymal stem cell proliferation activity part I: release characteristics Chem. Today 26 30
16. Hosseinkhani H, Azzam T, Tabata Y and Domb A J 2004 Dextran-spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection Gene Ther. 11 194
17. Hosseinkhani H, Hosseinkhani M, Tian F, Kobayashi H and Tabata Y 2007 Bone regeneration on a collagen sponge self-assembled peptide-amphiphile nanofiber hybrid scaffold Tissue Eng. 13 11
18. Kabanov A V, Nazarova I R, Astafieva I V, Batrakova E V, Alakhov V Y, Yaroslavov A A and Kabanov V A 1995 Micelle formation and solubilization of fluorescent-probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions Macromolecules 28 2303
19. Nagarajan R 2001 Solubilization of 'guest' molecules into polymeric aggregates Polym. Adv. Technol. 12 23
20. Amiji M M, Lai P K, Shenoy D B and Rao M 2002 Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation Pharm. Dev. Technol. 7 195
21. Grindel J M, Jaworski T, Piraner O, Emanuele R M and Balasubramanian M 2002 Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans J. Pharm. Sci. 91 1936
22. Nishiyama N, Bae Y, Miyata K, Fukushima S and Kataoka K 2005 Smart polymeric micelles for gene and drug delivery Drug Discov. Today Technol. 2 21
23. McGuire W P, Rowinsky E K, Rosenshein N B, Grumbine F C, Ettinger D S, Armstrong D K and Donehower R C 1989 Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms Ann. Intern. Med. 11 1
24. Gagandeep S, Novikoff P M, Ott M and Gupta S 1999 Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines Cancer Res. 136 109
25. Spencer C M and Faulds D 1994 Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer Drugs 48 794
26. Zhao Q, Han B, Wang Z, Gao C, Peng C and Shen J 2007 Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studies Nanomedicine 3 63
27. Schmitt-Sody M, Strieth S, Krasnici S, Sauer B, Schulze B, Teifel M, Michaelis U, Naujoks K and Dellian M 2003 Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy Clin. Cancer Res. 9 2335
28. Nahar M et al 2006 Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives Crit. Rev. Ther. Drug Carrier Syst. 23 259
29. Cegnar M, Kristl J and Kos J 2005 Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours Expert Opin. Biol. Ther. 5 1557
30. Kommareddy S, Tiwari S B and Amiji M M 2005 Long-circulating polymeric nanovectors for tumor-selective gene delivery Technol. Cancer Res. Treat. 4 615
31. Gamo T, Inokuchi T and Laufer H 1977 Polypeptides of fibroin and sericin secreted from the different section of the silk gland in Bombyx mori Insect Biochem. 7 285
32. Freddi G, Mossotti R and Innocenti R 2003 Degumming of silk fabric with several proteases J. Biotechnol. 106 101
33. Zhang Y Q 2002 Applications of natural silk protein sericin in biomaterials Biotechnol. Adv. 20 91
34. Cho K Y, Moon J Y, Lee Y W, Lee K G, Yeo J H, Kweon H Y, Kim K H and Cho S C 2003 Preparation of self-assembled silk sericin nanoparticles Int. J. Biol. Macromol. 32 36
35. Ahn J S, Choi H K, Lee K H, Nahm J H and Cho C S 2001 Novel mucoadhesive polymer prepared by template polymerization of acrylic acid in the presence of silk sericin J. Appl. Polym. Sci. 80 274
36. Nagura M, Ohnishi R, Gitoh Y and Ohkoshi Y 2001 Structure and physical properties of cross-linked sericin membranes J. Seric. Sci. Japan 70 149
37. Panilaitis B, Altman G H, Chen J, Jin H J, Karageorgiou V and Kaplan D L 2003 Macrophage response to silk Biomaterials 24 3079
38. Zhang Y Q, Tao M L, Shen W D, Mao J P and Chen Y H 2006 Synthesis of silk sericin peptides-L-asparaginase (SS-ASNase) bioconjugates and their characterization J. Chem. Technol. Biotechnol. 81 136
39. Zhang Y Q, Ma Y, Xia Y Y, Shen W D, Mao J P and Xue R Y 2006 Silk sericin-insulin bioconjugates: Synthesis, characterization and biological activity J. Control Release 115 307
40. Mandal B B and Kundu S C 2008 A novel method for dissolution and stabilization of non mulberry silk gland protein fibroin using anionic surfactant sodium dodecyl sulphate Biotechnol. Bioeng. 99 1482
41. Mandal B B and Kundu S C 2008 Non-bioengineered silk gland fibroin protein: characterization and evaluation of matrices for potential tissue engineering applications Biotechnol. Bioeng. 100 1237
42. Mandal B B and Kundu S C 2008 Non-bioengineered silk fibroin protein 3D scaffolds for potential biotechnological and tissue engineering applications Macromol. Biosci. 8 807
43. Mandal B B, Das T and Kundu S C 2009 Non-bioengineered silk gland fibroin micromolded matrices to study cell-surface interactions Biomed. Microdevices 11 467-76
44. Vepari C and Kaplan D L 2007 Silk as a biomaterial Prog. Polym. Sci. 32 991
45. Mandal B B, Priya A S and Kundu S C 2009 Novel silk sericin/gelatin 3-D scaffold and 2-D films: fabrication and characterization for potential tissue engineering applications Acta Biomater. doi:10.1016/j.actbio.2009.03.026
46. Rapoport N, Pitt W G, Sun H and Nelson J L 2003 Drug delivery in polymeric micelles: from in vitro to in vivo J. Control. Release 91 85
47. Schmolka I R 1972 Artificial skin I: preparation and properties of Pluronic-127 gels for treatment of burns J. Biomed. Mater. Res. 6 571
48. Miyazaki S, Tobiyama T, Takada M and Attwood D 1995 Percutaneous absorption of indomethacin from pluronic F-127 gels in rats J. Pharm. Pharmacol. 47 455
49. Stratton L P, Dong A, Manning M C and Carpenter J F 1997 Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel J. Pharm. Sci. 86 1006
50. Wang P L and Johnston T P 1993 Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407 J. Parenter. Sci. Technol. 47 183
51. Cavallaro G, Maniscalco L, Licciardi M and Giammona G 2004 Tamoxifen loaded polymeric micelles: preparation, physio-chemical characterization and in vitro evaluation studies Macromol. Biosci. 4 1028
52. Dash R, Mukherjee S and Kundu S C 2006 Isolation, purification and characterization of silk protein sericin from cocoon peduncles of tropical tasar silkworm, Antheraea mylitta Int. J. Biol. Macromol. 38 255
53. Davda J and Labhasetwar V 2002 Characterization of nanoparticle uptake by endothelial cells Int. J. Pharm. 233 51
54. Yang J, Zeng J, Kong T, Wang X, Roa W, El-Bialy T, Xing J and Chen J 2007 The effect of surface properties of gold nanoparticles on cellular uptake (LISSA 2007): IEEE/NIH Life Science Systems and Applications Workshop p92
55. Chithrani B D, Ghazani A A and Chan W C W 2006 Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano Lett. 6 662
56. Huff T B, Hansen M N, Zhao Y, Cheng J X and Wei A 2007 Controlling the cellular uptake of gold nanorods Langmuir 23 1596
57. Chawla J S and Amiji M M 2003 Cellular uptake and concentration of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticles AAPS Pharmsci. 5 1
58. Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C 1995 A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine on early apoptotic cells using fluorescein labeled Annexin V J. Immunol. Methods 184 39
59. Martin S J, Reutelingsperger C P, McGahon A J, Rader J A, van Schie R C, LaFace D M and Green D R 1995 Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl J. Exp. Med. 182 1545
60. Mooney L M, Al-Sakkaf K A, Brown B L and Dobson P R M 2002 Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells Br. J. Cancer 87 909
61. Shimizu S, Eguchi Y, Kamiike K, Waguli S, Uchiyama Y, Matsuda H and Tsujimoto Y 1996 Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors Oncogene 13 21
62. Susin S A, Zamzami N, Castedo M, Daugas E, Wang H G, Geley S, Fassy F, Reed J C and Kroemer G 1997 The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/ CD-95-and ceramide-induced apoptosis J. Exp. Med. 186 25
63. Yang J, Liu X, Bhalla K, Kim C N, Ibrado A M, Cai J, Peng T, Jones D P and Wang X 1997 Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked Science 275 1129